Algert Global LLC decreased its holdings in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 8.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,287 shares of the company’s stock after …